Vertex facing lawsuit from disgruntled investors
CAMBRIDGE, Mass. Vertex Pharmaceuticals’ investors had a class action lawsuit filed for them in the U.S. District Court for the District of Massachusetts.
The suit, which was filed by the Dreier law firm, alleges the company misled investors by making false and misleading statements concerning the development of Vertex’s new HCV protease inhibitor, telaprevir, also named VX-950. Vertex intends to use the inhibitor in a new drug for hepatitis C.
The suit claims the company made positive statements about the progress of the drug’s PROVE 2 trial while withholding negative findings. A later release of all the data from the trial caused the company’s stock price to decline by 9 percent, according to the lawsuit.
Sugar may be helpful for those with diabetes and obesity
BALTIMORE Researchers have found a new treatment that may be helpful in aiding those with diabetes and obesity, and it is most unusually a sugar.
The sugar is known as tagatose, which, according to published reports, is used in Europe to sweeten candy or orange juice. It is a naturally occurring version of fructose and is derived from the dairy byproduct whey. Tagatose has been shown to stop blood sugar spiking and is currently undergoing a one-year clinical trial to see if is, in fact, helpful in managing diabetes and weight-loss.
According to the American Diabetes Association, about 20.8 million people are diabetic and 9 out of 10 diabetics with Type 2 are overweight. Many researchers, such as Phillip Levin, an endocrinologist and director of diabetes center at Mercy, hope that tagatose can become a diet drug for patients experiencing obesity, one of the leading causes of diabetes. According to Levin, “Tagatose could be another tool for damage control. A lot of dealing with Type 2 diabetes is damage control.”
Other studies have shown that tagatose, if ingested before meals, would stop the rise in blood sugar, because it is absorbed poorly and therefore affects the way the sugar is stored. According to published reports, tagatose is said to be possibly the only diabetes drug that could raise good cholesterol and act as a cell-protecting antioxidant.
FDA to take a closer look at Singulair
WASHINGTON The Food and Drug Administration has warned health care professionals that it is investigating possible side effects in the asthma drug Singulair.
Possible side effects of the drug, a Merck product, include behavior/mood changes, suicidality and suicide.
The agency will need up to nine months to complete ongoing evaluations about the safety of the drug.
“Patients should not stop taking Singulair before talking to their doctor if they have questions about this new information,” the FDA said. “Until further information is available, healthcare professionals and caregivers should monitor patients taking Singulair for suicidality and changes in behavior and mood.”